1.World Health Assembly. Global eradication of poliomyelitis by the year 2000. Geneva, Switzerland: WHA resolution no. WHA41.28, 1988.
2.WHO. Field guide for supplementary activities aimed at achieving polio eradication, publication no. WHO/EPI/GEN/95.1. Geneva: World Health Organization, 1995.
4.Rico-Hesse, R, et al. Geographic distribution of wild poliovirus type 1 genotypes. Virology 1987; 160: 311–322.
5.Anon.Progress towards interrupting wild poliovirus transmission worldwide, 2008. Weekly Epidemiological Records 2009: 84; 110–116.
6.Roberts, L. Polio eradication. Looking for a little luck. Science 2009; 323: 702–705.
7.Anon.Resurgence of wild poliovirus types 1 and 3 in 15 African countries, January 2008–March 2009. Weekly Epidemiological Records 2009; 84: 133–140.
8.Anon.CDC Update on vaccine-derived polioviruses – worldwide, January 2008–June 2009. Mobridity and Mortality Weekly Report 2009; 58: 1002–1006.
10.Dowdle, W, et al. Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management. Risk Analysis 2006; 26: 1449–1469.
11.Ranta, J, Hovi, T, Arjas, E. Poliovirus surveillance by examining sewage water specimens: studies on detection probability using simulation models. Risk Analysis 2001; 21: 1087–1096.
12.Hovi, T, et al. Poliovirus surveillance by examining sewage specimens. Quantitative recovery of virus after introduction into sewerage at remote upstream location. Epidemiology and Infection 2001; 127: 101–106.
13.Hovi, T, et al. Environmental surveillance of wild poliovirus circulation in Egypt – balancing between detection sensitivity and workload. Journal of Virological Methods 2005; 126: 127–134.
14.Manor, Y, et al. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. Journal of Clinical Microbiology 1999; 37: 1670–1675.
15.Manor, Y, et al. Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002. Applied and Environmental Microbiology 2007; 73: 5954–5958.
16.Hovi, T, et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986; 1: 1427–1432.
17.Kinnunen, E, Hovi, T, Stenvik, M. Outbreak of poliomyelitis in Finland in 1984. Description of nine cases with persisting paralysis. Scandinavian Journal of Infectious Diseases 1986; 18: 15–18.
18.Pöyry, T, Stenvik, M, Hovi, T. Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Applied and Enviromental Microbiology 1988; 54: 371–374.
19.Slater, PE, et al. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet 1990; 335: 1192–1195; discussion 1196–1198.
20.Shulman, LM, et al. Resolution of the pathways of poliovirus type 1 transmission during an outbreak. Journal of Clinical Microbiology 2000; 38: 945–952.
21.Oostvogel, PM, et al. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992–93. Lancet 1994; 344: 665–670.
22.van der Avoort, HG, et al. Isolation of epidemic poliovirus from sewage during the 1992–3 type 3 outbreak in The Netherlands. Epidemiology and Infection 1995; 114: 481–491.
23.El Bassioni, L, et al. Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. American Journal of Epidemiology 2003; 158: 807–815.
24.World Health Organization.Global detection of wid and vaccine-derived polioviruses, January 2008–June 2009. Weekly Epidemiological Records 2009; 36: 366–371.
25.Tambini, G, et al. Direct detection of wild poliovirus circulation by stool surveys of healthy children and analysis of community wastewater. Journal of Infectious Diseases 1993; 168: 1510–1514.
26.Deshpande, JM, Shetty, SJ, Siddiqui, ZA. Environmental surveillance system to track wild poliovirus transmission. Applied and Environmental Microbiology 2003; 69: 2919–2927.
27.Chowdhary, R, Dhole, TN. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India. Journal of Medical Virology 2008; 80: 1477–1488.
28.Korotkova, EA, et al. Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future. Journal of Virology 2003; 77: 12460–12465.
29.Kew, O, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002; 296: 356–359.
30.Anon.Paralytic poliomyelitis in Madagascar, 2002. Weekly Epidemiological Records 2002; 77: 241–242.
31.Dowdle, WR, et al. Polio eradication: the OPV paradox. Reviews in Medical Virology 2003; 13: 277–291.
32.Shimizu, H, et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. Journal of Virolology 2004; 78: 13512–13521.
33.Kew, OM, et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bulletin of World Health Organization 2004; 82: 16–23.
34.Liang, X, et al. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. Journal of Infectious Diseases 2006; 194: 545–551.
35.Tebbens, RJ, et al. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Analysis 2006; 26: 1471–1505.
36.Rakoto-Andrianarivelo, M, et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. Journal of Infectious Diseases 2008; 197: 1427–1435.
37.Estívariz, CF, et al. A large vaccine-derived poliovirus outbreak on Madura Island – Indonesia, 2005. Journal of Infectious Diseases 2008; 197: 347–354.
38.Jenkins, HE, et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. New England Journal of Medicine 2010; 362: 2360–2369.
39.Gumede, N, et al. Identification of vaccine-derived polioviruses (VDPVS) in the DRC from 2005 to 2010. Communicable Diseases Surveillance Bulletin 2010; 8: 43–45.
40.Más Lago, P, et al. Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba. International Journal of Epidemiology 2003; 32: 772–777.
41.Huang, QS, et al. Persistence of oral polio vaccine virus after its removal from the immunization schedule in New Zealand. Lancet 2005; 366: 394–396.
42.Kew, OM, et al. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annual Reviews of Microbiology 2005; 59: 587–635.
43.Dedepsidis, E, et al. Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece. Applied and Environmental Microbiology 2007; 73: 6697–6704.
44.Vinjé, J, et al. Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola. Journal of Infectious Diseases 2004; 189: 1168–1175.
45.Pavlov, DN, et al. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa. Water Research 2005; 39: 3309–3319.
46.Bundesamt fur Gesundheit.Communicable diseases. European Region of World Health Organization free of wild virus-induced poliomyelitis for five years [in German]. Bulletin BAG 2007; 46: 824–826.
47.Shulman, LM, et al. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. PLoS ONE 2006; 1: e69.
48.Shulman, LM, et al. Type 2 polio still in our midst. Science 2009; 324: 334.
49.Blomqvist, S, et al. Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. Journal of Virology 2004; 78: 4876–4883.
50.Cernáková, B, et al. Isolation of vaccine-derived polioviruses in the Slovak Republic. European Journal of Clinical Microbiology & Infectious Diseases 2005; 24: 438–439.
51.Roivainen, M, et al. Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage. Eurosurveillance 2010; 15.